Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

IGFBP2

Introduction

Insulin-like growth factor-binding protein 2 is a protein that in humans is encoded by the IGFBP2 gene.[1]

References

References

  1. ↑ Zapf J, Kiefer M, Merryweather J, Musiarz F, Bauer D, Born W, Fischer JA, Froesch ER (Oct 1990). “Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF I administration and in extrapancreatic tumor hypoglycemia”. J Biol Chem. 265 (25): 14892–8. PMID 1697583.
Further reading

Further reading

  • Rajaram S, Baylink DJ, Mohan S (1997). “Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions”. Endocr. Rev. 18 (6): 801–31. doi:10.1210/er.18.6.801. PMID 9408744.
  • Wolf E, Lahm H, Wu M, et al. (2000). “Effects of IGFBP-2 overexpression in vitro and in vivo”. Pediatr. Nephrol. 14 (7): 572–8. doi:10.1007/s004670000362. PMID 10912521.
  • Chesik D, De Keyser J, Wilczak N (2007). “Insulin-like growth factor binding protein-2 as a regulator of IGF actions in CNS: implications in multiple sclerosis”. Cytokine Growth Factor Rev. 18 (3–4): 267–78. doi:10.1016/j.cytogfr.2007.04.001. PMID 17485236.
  • Binkert C, Margot JB, Landwehr J, et al. (1992). “Structure of the human insulin-like growth factor binding protein-2 gene”. Mol. Endocrinol. 6 (5): 826–36. doi:10.1210/me.6.5.826. PMID 1376411.
  • Zhou J, Bondy C (1992). “Insulin-like growth factor-II and its binding proteins in placental development”. Endocrinology. 131 (3): 1230–40. doi:10.1210/en.131.3.1230. PMID 1380437.
  • Ehrenborg E, Vilhelmsdotter S, Bajalica S, et al. (1991). “Structure and localization of the human insulin-like growth factor-binding protein 2 gene”. Biochem. Biophys. Res. Commun. 176 (3): 1250–5. doi:10.1016/0006-291X(91)90420-C. PMID 1710112.
  • Agarwal N, Hsieh CL, Sills D, et al. (1991). “Sequence analysis, expression and chromosomal localization of a gene, isolated from a subtracted human retina cDNA library, that encodes an insulin-like growth factor binding protein (IGFBP2)”. Exp. Eye Res. 52 (5): 549–61. doi:10.1016/0014-4835(91)90056-K. PMID 1712312.
  • Roghani M, Lassarre C, Zapf J, et al. (1991). “Two insulin-like growth factor (IGF)-binding proteins are responsible for the selective affinity for IGF-II of cerebrospinal fluid binding proteins”. J. Clin. Endocrinol. Metab. 73 (3): 658–66. doi:10.1210/jcem-73-3-658. PMID 1714916.
  • Clemmons DR, Snyder DK, Busby WH (1991). “Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects”. J. Clin. Endocrinol. Metab. 73 (4): 727–33. doi:10.1210/jcem-73-4-727. PMID 1716260.
  • Roghani M, Segovia B, Whitechurch O, Binoux M (1993). “Purification from human cerebrospinal fluid of insulin-like growth factor binding proteins (IGFBPs). Isolation of IGFBP-2, an altered form of IGFBP-3 and a new IGFBP species”. Growth Regul. 1 (3): 125–30. PMID 1726837.
  • Rosenfeld RG, Pham H, Conover CA, et al. (1989). “Structural and immunological comparison of insulin-like growth factor binding proteins of cerebrospinal and amniotic fluids”. J. Clin. Endocrinol. Metab. 68 (3): 638–46. doi:10.1210/jcem-68-3-638. PMID 2465304.
  • Binkert C, Landwehr J, Mary JL, et al. (1989). “Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2)”. EMBO J. 8 (9): 2497–502. PMC 401241. PMID 2479552.
  • Ilvesmäki V, Blum WF, Voutilainen R (1994). “Insulin-like growth factor binding proteins in the human adrenal gland”. Mol. Cell. Endocrinol. 97 (1–2): 71–9. doi:10.1016/0303-7207(93)90212-3. PMID 7511544.
  • Zhou J, Bondy C (1993). “Anatomy of the human ovarian insulin-like growth factor system”. Biol. Reprod. 48 (3): 467–82. doi:10.1095/biolreprod48.3.467. PMID 7680905.
  • Han VK, Bassett N, Walton J, Challis JR (1996). “The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface”. J. Clin. Endocrinol. Metab. 81 (7): 2680–93. doi:10.1210/jc.81.7.2680. PMID 8675597.
  • Bach LA, Rechler MM (1996). “Measurement of insulin-like growth factor (IGF)-II binding to purified IGF binding proteins 1-6: comparison of charcoal adsorption and high performance size exclusion chromatography”. Biochim. Biophys. Acta. 1313 (1): 79–88. doi:10.1016/0167-4889(96)00053-5. PMID 8781553.
  • Ho PJ, Baxter RC (1997). “Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia”. Clin. Endocrinol. 46 (3): 333–42. doi:10.1046/j.1365-2265.1997.1100922.x. PMID 9156044.
  • Wong MS, Fong CC, Yang M (1999). “Biosensor measurement of the interaction kinetics between insulin-like growth factors and their binding proteins”. Biochim. Biophys. Acta. 1432 (2): 293–301. doi:10.1016/S0167-4838(99)00106-5. PMID 10407151.